UK pharmaceutical company AstraZeneca has reached a settlement with Actavis and Egis Pharmaceuticals that delays the release of generic versions of its cholesterol treatment Crestor.
If you have already subscribed please login.
If you have any technical issues please email tech support.
AstraZeneca, Watson, Actavis, Egis, Crestor, settlement, generic
